Anvendelse av 2-hydroksy- eller 2-acetyloksy-4-trifluormetylbenzosyrederivater som et middel for behandlingen og forebyggingen av mild kognitiv svekkelse

The present invention relates to the use of 2-hydroxy or 2-acetyloxy-4-trifluoromethylbenzoic acid, respectively, for the treatment or prevention of mild cognitive impairment (MCI) in mammals, especially in human beings. Futhermore, the present invention also concerns the use of 2-hydroxy or 2-acety...

Full description

Saved in:
Bibliographic Details
Main Authors PULIDO JOSE IGNACIO LZQUIERDO, ORTI GENIS MUNOZ, RAMIREZ JOSE CARLOS NAVAS, GARCIA-RAFANELL JULIAN
Format Patent
LanguageNorwegian
Published 01.07.2004
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to the use of 2-hydroxy or 2-acetyloxy-4-trifluoromethylbenzoic acid, respectively, for the treatment or prevention of mild cognitive impairment (MCI) in mammals, especially in human beings. Futhermore, the present invention also concerns the use of 2-hydroxy or 2-acetyloxy-4-trifluoromethylbenzoic acid, respectively, for delaying or preventing the conversion of MCI into dementia, especially Alzheimer's Disease.
Bibliography:Application Number: NO20040002785